Flat Medical Strengthens Market Leadership with Acquisition of InjeQ Assets, Including FDA-Designated Breakthrough Device IQ-Tip®
TAIPEI, Sept. 25, 2024 /PRNewswire/ -- Flat Medical, a leading innovator in medical technology, today announced its acquisition of key assets from InjeQ, including the FDA-designated breakthrough device, IQ-Tip®. This strategic move bolsters Flat Medical's leadership position in the medical device market and expands its portfolio of cutting-edge healthcare solutions. The acquisition includes InjeQ's intellectual property, technology assets,...
SI GROUP ANNOUNCES PLANS TO CLOSE MANUFACTURING SITE IN SINGAPORE
Company plans to cease manufacturing operations in second half of 2025 due to declining market conditions THE WOODLANDS, Texas, Sept. 25, 2024 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced it plans to close its alkylphenol manufacturing facility located...
Samsung Biologics launches development platforms for enhanced therapeutic efficacy
Samsung Biologics showcases new innovative development platforms – S-AfuCHOTM and S-OptiChargeTM – at BioProcess International 2024 New technology platforms to proactively address evolving industry trends and enable high-quality development INCHEON, South Korea, Sept. 25, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), launched today...
CariGenetics And One BioMed Strike Partnership to Advance Genomic Testing in the Caribbean – Decentralised Approach Serves the Needs of the Caribbean Community
HAMILTON, Bermuda, Sept. 25, 2024 /PRNewswire/ -- CariGenetics and One BioMed are proud to announce their strategic partnership to bring One BioMed's Xceler8 Platform across the Caribbean. Implementing this cutting-edge technology in the region marks a major advancement in the field of Caribbean genomic research. One BioMed's Xceler8 Platform enables more efficient, streamlined high molecular weight (HMW) DNA extractions...
New Research from the International Coaching Federation Highlights Trends in Workplace Burnout
- Demand for mental well-being support becoming widespread - LEXINGTON, Ky., Sept. 25, 2024 /PRNewswire/ -- New research, released today by the International Coaching Federation (ICF), indicates growing workplace demand for mental well-being support. With mental well health concerns including burnout rising worldwide, the new study indicates that as many as 85% of coaching professionals working with clients on...
GSK’s Arexvy is a vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia
Adults aged 60 and over with underlying co-morbidities are at high risk of developing severe infections from RSV Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy observed in adults with co-morbidities vii KUALA LUMPUR, Malaysia, Sept. 25, 2024 /PRNewswire/ -- GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in...
FONDAZIONE PRADA PRESENTS “PRESERVING THE BRAIN: A CALL TO ACTION” IN MILAN
MILAN, Sept. 25, 2024 /PRNewswire/ -- The new edition of "Preserving the Brain," part of Fondazione Prada's "Human Brains" project dedicated to neurosciences since 2018, will focus on the prevention of neurodegenerative diseases. Organized in partnership with fifteen renowned neuroscience institutes from world-class universities and five Italian patient organizations and associations, "Preserving...
Belief BioMed to Collaborate with AskBio to Explore the Potential of New Gene Therapies
Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach. SHANGHAI, Sept. 25, 2024 /PRNewswire/ -- Belief BioMed Inc. (BBM), a biotech company focusing on innovative gene therapies, today announced a new strategic collaboration with Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly...
Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024
Switching between adalimumab and adalimumab-fkjp in Phase 3 study in patients with chronic plaque psoriasis supports interchangeability between adalimumab and adalimumab-fkjp Biosimilarity between Bmab 1200 and reference biologic-Ustekinumab in pivotal Phase 3 trial in patients with moderate to severe chronic plaque psoriasis AMSTERDAM and BENGALURU, India, Sept. 25, 2024...
Get To Know Severe Asthma: The Chronic, Life-Threatening Condition Affecting 7-11% Adults In Asian Countries
KUALA LUMPUR, Malaysia, Sept. 25, 2024 /PRNewswire/ -- Asthma is well-known as a common respiratory condition. But did you know that there exists a life-threatening type of the condition called severe asthma, that requires specialised, multidisciplinary treatment to manage? Severe asthma is estimated to affect 7% to 11% of adults in Asian countries, while worldwide the condition affects 3%-10%...
